BioNumerik Pharmaceuticals
San Antonio · Founded 1992
About BioNumerik Pharmaceuticals
BioNumerik Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drugs that help in the treatment of cancer. The company’s two oncology drug candidates, Tavocept and BNP1350, are in late-stage clinical development. BioNumerik Pharmaceuticals, Inc. was founded in 1992 and is based in San Antonio, Texas.
Company Facts
- Founded: 1992
- Legal name: BioNumerik Pharmaceuticals Inc.
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $63.3M
- Last round: Series Unknown (Nov 2012)
- Website: bionumerik.com
- Phone: 210-614-1701
Social Profiles
Canonical: https://fsome.com/organization/bionumerik-pharmaceuticals-8379790 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.